Thus, the primary aim of this randomized controlled trial was to evaluate the effects of dihydrogen supplementation on body composition indices, appetite, obesity-specific quality of life, and circulating GLP-1 levels in obese men and women. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.